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Glossopharyngeal Neuralgia as Onset of Multiple Sclerosis
Pietro Biagio Carrieri, MD, Silvana Montella, MD, and Maria Petracca, MD
Objectives and Methods: Glossopharyngeal neuralgia is a painful
condition, aﬀecting the ninth cranial nerve, rarely described in the
course of multiple sclerosis. Here we describe a case of multiple
sclerosis presenting with glossopharyngeal neuralgia.
Results and Discusion: We suggest the presence of demyelinating
areas at the nerve root entry zone as principal trigger mechanism.
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Pain is a common problem of persons with multiplesclerosis (MS), the most common central nervous
system demyelinating disease, and it has been recently
recognized as an important factor in their overall health-
related quality of life.1,2 Nevertheless, estimates of pain
prevalence can vary widely from 29% to 86% lifetime,
whereas at the onset of disease its prevalence ranges from
11% to 23%.3 One of us (P.B.C.) already found that 57%
of MS patients reported pain syndromes at some time
during the MS course, whereas 21% reported pain as a
symptom at onset of MS.4 The type of pain more frequently
aﬀecting MS patients are headache (12% to 22%), back
pain (10% to 16%), Lhermitte sign (9% to 13%), and
trigeminal neuralgia (TN; 1% to 2%).3 In contrast,
glossopharyngeal neuralgia (GPN), a condition originally
described in 1910,5 represents a rarer manifestation of pain
during MS.
The glossopharyngeal nerve exits the brainstem out
from the sides of the upper medulla. It supplies motor ﬁbers
to stylopharyngeus muscle and it contributes to the
pharyngeal plexus. It also supplies parasympathetic ﬁbers
to the parotid gland through the otic ganglion. Finally, it
receives sensory ﬁbers from the posterior one-third of the
tongue, tonsils, pharynx, middle ear, and carotid sinus.
GPN is characterized by recurring attacks of severe
pain in the back of the throat and tongue, in the area near
the tonsils, and part of the ear. Pain lasts for seconds to
minutes in duration. Attacks may be triggered by particular
actions, such as chewing, swallowing, talking, coughing, or
sneezing. In some cases, even sudden movements of the
head or raising the arm on the side of the pain could
precipitate GPN.6 It aﬀects the left side more frequently
and symptoms usually begin in people above the age of 40
years,7 with a peak-age at onset between 40 and 60, and
left-side involvement predominates in females.6 With time,
the features of pain may become more atypical, with greater
areas of more enduring and dull pain and occasionally
bilateral, rarely on both sides simultaneously. As regard the
natural history of GPN, patients can experience a remission
of pain, even though clusters have an irregular course.8
In the general population, incidence of GPN seems to
be 0.7 per 100,000/y (0.9 in men and 0.5 in women),9 0.7%
to 1.0% of that of TN.10 GPN has also been rarely
described in the course of MS; in MS patients, its incidence
is about 0.5 per 1000, in contrast to that of TN, which has
an incidence of 40 per 1000.11 GPN may be associated with
TN, accounting for 8% to 11%.8
Treatment of pain in MS icludes the use of anti-
epileptic drugs, muscle relaxers/antispasmodic agents, and
anti-inﬂammatory drugs. Minagar and Sheremata11 re-
ported 4 cases of MS complicated by GPN. Relief of
symptoms was obtained after the administration of
carbamazepine, 1000mg daily.
In our study, we describe a case of MS presenting with
GPN. The appearance of GPN as onset of the pathology is
an original description. The patient, a 41-year-old woman,
came at our observation at the Department of Neurological
Sciences of the University of Naples ‘‘Federico II,’’ Naples,
Italy. She described paroxysm of excruciating, knife-like
pain, referred to back of the tongue, pharynx, and part of
the ear, exclusively to the left side. Each paroxysm started
or worsened with swallowing, coughing, brushing her teeth,
or eating and usually lasted for seconds to a few minutes.
After each episode, there was usually a refractive period
during which stimulation of the trigger zone did not induce
pain. The attacks occurred several times a day and had
started 1 month earlier. An otolaryngologist concurred with
a diagnosis of GPN. She had no history of previous
diseases, except for blood hypertension treated with
nifedipine 30mg/d. Neurologic examination was normal.
The brain gadolinium-enhanced magnetic resonance ima-
ging (MRI) scan, performed to investigate the causes of
GPN, showed some small rounded areas of increased signal
on T2-weighted images in the centrum semiovale and
periventricular regions. MR angiography (MRA) of the
cerebellopontine angle had been also performed and
revealed no pathologic elements. Blood tests were normal.
We treated our patient with carbamazepine (up to
800mg/d) with partial relief of pharyngeal pain after 30
days from the beginning of treatment. Three months later,
the patient spontaneously reduced the dosing of carbama-
zepine with the reactivation of pain, which responded to the
rechallenge with therapy. After 6 months, the patient
developed weakness in the left leg and widespread
paresthesia. Neurologic examination revealed paraparesis
with brisk tendon reﬂexes in the legs, especially in the left
one, with a clear extensor plantar response; the expandedCopyright r 2009 by Lippincott Williams & Wilkins
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disability status scale was 3.5.12 A new MRI showed further
demyelinating lesions on T2-weighted scans in the centrum
semiovale, periventricular regions, white matter of left
temporal lobe (Fig. 1), and dorsal spine (Fig. 2), with
enhancement after intravenous injection of gadolinium.
Cerebrospinal ﬂuid (CSF) examination showed normal
glucose, protein, and cell count, but oligoclonal bands were
present (Fig. 3). Albumin and IgG in the CSF and serum
were measured with Behring Nephelometer analyzer (Dade
Behring, Germany).
The method we used for the detection of oligoclonal
bands is isoelectric focusing (IEF), performed as previously
described by Keir et al.13 Brieﬂy, IEF gel was prepared with
IEF agarose, Pharmalyte pH 3 to 10, and Pharmalyte pH 8 to
10.5 (Amersham Biosciences); and focusing was performed
on a Multiphor II apparatus (Amersham Biosciences). The
electrode strips were soaked with 1M NaOH and 0.05M
SO4H2, and paired serum and CSF samples (3mL) were
applied on the anodic side of the gel. After focusing, the
proteins were transferred to a nitrocellulose membrane
(Millipore). The membrane was then incubated with alkaline
phosphatase-conjugated rabbit antihuman IgG and, ﬁnally,
stained using nitro blue tetrazolium and bromo-chloro-
indoleyl phosphate. We made diagnosis of MS according to
McDonald et al14 criteria.
A trial of intravenous methylprednisolone (1000mg/d
for 3 d, followed by 500mg/d for 2 d) resulted in relief of the
patient’s neurologic symptoms, including GPN. After 1
month, the patient started the b-interferon-1a (Rebif 44 3
times weekly) treatment to prevent further relapses. To
date, after 12 months from the beginning of treatment,
the patient shows no relevant neurologic alterations and
no GPN.
GPN has diﬀerent causes, but, in some cases, the
source of irritation of the ninth cranial nerve is not found.
The most common causes of GPN are vascular compres-
sion of nerve roots entering the lateral medulla or neck
tumors. In particular, vascular compression is thought to
cause pain through demyelination and ephaptic transmis-
sion.15 To ﬁnd out whether a blood vessel is pressing on the
nerve, pictures of the brain arteries may be taken using the
MRA or conventional angiography. GPN can also be
related to a neoplasia injuring the glossopharyngeal nerve
in the neck or in the skull base, such as medullary,
laryngeal, or nasopharyngeal cancer. To identify tumors at
the base of the skull, computed tomography or MRI scan
of the head might be performed.
In our patient, MRA was normal and MRI showed no
tumors; therefore, the cause of GPN could be related to a
demyelinating plaque next to the nucleus of the ninth
nerve—too small to detect—or, especially, in the nerve root
entry zone. Also Paty and Ebers16 hypothesized that the
potential cause of the closely related TN in MS patients
could be appearance of demyelinating plaques at the root
entry zone of the trigeminal nerve. Our hypothesis was
supported by other studies, as well, demonstrating how
frequent and underrated is cranial nerves involvement in
FIGURE 1. Magnetic resonance imaging scan of multiple
rounded demyelinating areas in the white matter of the
periventricular regions and in the centrum semiovale in a T2-
weighted image.
FIGURE 2. Magnetic resonance imaging scan of dorsal spine: a
small rounded demyelinating area in a T2-weighted image.
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MS. Pichiecchio et al17 showed MRI enlargement of both
trigeminal nerves at the root entry zone, with gadolinium
enhancement of the cisternal portion in a MS patient with
sudden right TN. This is the ﬁrst description of peripheral
involvement of the trigeminal nerve in MS supported by
instrumental ﬁndings. In addition, Kenner et al2 suggest
that the pathophysiology of GPN in MS may be linked to
certain plaque location with the disruption of pain path-
ways and abnormal impulses through motor axons, or to
the development of an acquired channelopathy in aﬀected
nerves.
According to our observation, the injury of a cranial
nerve as onset of MS seems more frequent. In fact, the
involvement of other cranial nerves, such as the sixth, was
described as the initial manifestation of MS and related to a
demyelinating lesion in the pons.18,19
In conclusion, although cranial nerves are very small
structure, modern MRI has all options to reveal or rule out
their involvement. Therefore, the appearance in healthy
people of GPN, even without other neurologic abnorm-
ality, justiﬁes a brain MRI examination and also every
cranial neuralgia should be depth investigated. In our
opinion, demyelinating area at the root entry zone of
the glossopharyngeal nerve could be a potential cause of
GPN in MS patients, perhaps associated with ephaptic
conduction.
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FIGURE 3. Isoelectric focusing in agarose gel. Presence of
oligoclonal bands in cerebrospinal fluid (right) but not in serum
(left).
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